Study of SRF617 With AB928 (Etrumadenant) and AB122 (Zimberelimab) in Patients With Metastatic Castration Resistant Prostate Cancer
Clinical trial NCT05177770 · TERMINATED
Trial details
- NCT number
- NCT05177770
- Sponsor
- Coherus Oncology, Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-17
- Primary completion
- 2023-04-05
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.